Why is the Nanosonics share price jumping 10% on Wednesday?

Nanosonics shares are jumping on Wednesday…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nanosonics Ltd (ASX: NAN) share price is having a very strong day on Wednesday.

In afternoon trade, the infection prevention company's shares are up over 10% to $3.96.

Three businesspeople leap high with the CBD in the background.

Image source: Getty Images

What's going on with the Nanosonics share price?

Investors have been bidding the Nanosonics share price higher today despite there being no news out of the company.

However, it is worth highlighting that the healthcare sector is performing strongly today, as are a range of beaten down shares.

In respect to the former, in afternoon trade the S&P/ASX 200 Health Care index is up a sizeable 2%. That's despite the ASX 200 index trading 0.5% at the time of writing.

As for the latter, a number of beaten down ASX shares are recording double digit gains on Wednesday. This includes the likes of Life360 Inc (ASX: 360), Megaport Ltd (ASX: MP1), Mesoblast limited (ASX: MSB), and Zip Co Ltd (ASX: ZIP).

Some investors appear to believe that the selling has been overdone and now is the time to pounce.

Anything else?

Nanosonics is one of the most shorted shares on the Australian share market. At the last count, the company had over 12% of its shares in the hands of short sellers.

If some short sellers have decided to close positions, then they could be boosting the buy side by buying shares today.

Whatever the reason, with the Nanosonics share price still down ~40% in 2022, shareholders will no doubt be hoping there are more strong gains to come.

Motley Fool contributor James Mickleboro has positions in Life360, Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, Inc., MEGAPORT FPO, Nanosonics Limited, and ZIPCOLTD FPO. The Motley Fool Australia has positions in and has recommended Nanosonics Limited. The Motley Fool Australia has recommended MEGAPORT FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Man with a sleep apnoea mask on whilst sleeping.
Healthcare Shares

Why ResMed shares are tumbling 6% today despite strong results

Here's what spooked investors.

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Imricor Medical Systems shares: Philips declares compatibility for iMR products

Big news is catching the eye of investors on Friday.

Read more »

Broker looking at the share price on her laptop with green and red points in the background.
Earnings Results

ResMed posts strong Q4 earnings, lifts dividend

The sleep disorder treatment company had another record quarter.

Read more »

a doctor wearing a white coat with a stethoscope around her neck stares out a window with her hand to the side of her face as though in deep thought.
Healthcare Shares

Clarity Pharmaceuticals reports clinical trial milestones

Clarity Pharmaceuticals reported continued clinical progress for its prostate cancer imaging and therapy programs.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

Are Neuren Pharmaceuticals shares a buy, hold or sell after rocketing 16%?

This healthcare stock keeps rising.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Clarity Pharmaceuticals reports new SECuRE trial responses at higher dose

Clarity Pharmaceuticals reports further progress in its SECuRE prostate cancer trial, showing strong PSA responses and new complete responses at…

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Neuren Pharmaceuticals share price rockets: record Q2 DAYBUE sales and royalty upgrade

Second quarter net sales of DAYBUE increased 30%.

Read more »